Japan approves three new lung drugs from Western firms – Reuters

Japan approves three new lung drugs from Western firms
Reuters
LONDON (Reuters) – Japan has approved three new lung drugs from Western companies, underscoring how the world's second-biggest medicines market is opening up as an important growth driver for international pharmaceuticals groups. GlaxoSmithKline and

and more »

View full post on world asthma day – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *